Vaxxinity Inc. (NASDAQ:VAXX) traded at $3.19 at close of the session on Monday, 01/23/23, made an upward move of 6.33% on its previous day’s price.
Looking at the stock we see that its previous close was $3.00 with the day’s price range being $3.05 – $4.10. In terms of its 52-week price range, VAXX has a high of $8.88 and a low of $1.24. The company’s stock has gained about 115.54% over that past 30 days.
Vaxxinity Inc. has a market cap of $335.05 million and is expected to release its quarterly earnings report on Aug 11, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$0.15, with the EPS growth for the year raised at -$0.6 for 2022 and -$0.61 for next year. These figures represent 1.60% and -1.70% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the VAXX stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 50% Buy.
Based on estimates by 2 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Vaxxinity Inc. (VAXX) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 74.36% off its SMA20 and 77.03% from its 50-day simple moving average. The RSI (14) is pointing at 85.25 while the volatility over the past week is 24.30% and jumps to 14.88% over the past one month. The average price target for the stock over the next 12 months is $13.50, with the estimates having a low of $12.00 and a high of $15.00. These price ends are -276.18% and -370.22% off the current price level respectively, although investors could be excited at the prospect of a -323.2% if the VAXX share price touches on the median price of $13.50.
Let’s briefly compare Vaxxinity Inc. (VAXX) stock to its peers. We find that current price change of 6.33% and -59.82% over the past 12 months for VAXX competes that of Eli Lilly and Company (LLY), which has seen its stock price fall -1.12% in the last trading session and was 40.75% over the last one year. Another of its peers Merck & Co. Inc. (MRK) has dropped -0.05% previous session, and was 36.07% up over the past year. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at 1.19% and 0.76%, respectively, at close of the trading.
Coming back to Vaxxinity Inc. (NASDAQ:VAXX), we note that the average 3-month trading volume was 349.41K, while that of the preceding 10-day period stands at 0.25 million. Current shares outstanding are 126.04 million.
The insiders hold 47.00% of the company’s shares while institutions hold 23.40%. The data shows that short shares as of Oct 13, 2022, stood at 0.89 million at a short ratio of 4.5. This represents a 0.71% short interest in shares outstanding on Oct 13, 2022. Shares short rose in October from the previous month at 0.73 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 127.86% up in year-to-date price movement.